IRWD Q1 2017 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$603M

Q1 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$52M-21.0% YoY

Gross Profit

$52M99.0% margin

Operating Income

-$40M-76.1% margin

Net Income

-$53M-100.6% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

-40.4%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$29M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$701M

Total Liabilities

$672M

Stockholders' Equity

$30M

Cash & Equivalents

$133M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$66M	-21.0%
Gross Profit	$52M	$34M	+51.0%
Operating Income	-$40M	-$2M	-1917.5%
Net Income	-$53M	-$13M	-294.8%

Revenue Segments

Linaclotide

$200,000100%